New Science Ventures
Andrew Abrams has been a life sciences investor at New Science Ventures (NSV) since 2016 and is currently a Vice President. NSV currently manages over $700 million in assets and its portfolio includes therapeutic, medical device and diagnostic companies.
He was formerly a healthcare investment banker at J.P. Morgan in London focused on M&A and equity offerings and has also held operational roles at a large agricultural biotechnology company and a life science tools start-up.
Andrew obtained B.A., M.A. and M.Sci. degrees in Natural Sciences and Biochemistry from the University of Cambridge, and also holds an M.B.A. from Harvard Business School.
Andrew is attending / has attended:
Sign up now to stay up-to-date with all our events, news, deals and more!